The Neuropathology Core's main goal is to obtain, characterize, store and distribute for research, tissue specimens from longitudinally followed dementia patients and control research subjects from the Oregon Alzheimer Disease Center (OADC) Clinical Core, as well as selected patients from throughout the State of Oregon. All available specimens from subjects studied by the Center will be obtained and analyzed as rapidly as possible post-mortem. The Neuropathology Core will apply state-of-the-art, standardized protocols and staining methods to characterize the autopsy tissue quantitatively and semi-quantitatively and render a diagnosis. Approaches used to analyze tissue will include molecular, biochemical, immunological, histochemical and morphometric techniques. These methods will be applied to an increasing number of autopsy specimens from clinically well characterized individuals from the Clinical Core. Tissue will be provided to local and national investigators utilizing these tissues for hypothesis driven research and the development of novel probes and techniques. Data on brain and general autopsy will be entered into coded data forms, checked for accuracy and completeness and subsequently entered by the Data Management Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-13
Application #
6578732
Study Section
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
13
Fiscal Year
2002
Total Cost
$158,272
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Goodman, James R; Adham, Zachariah O; Woltjer, Randall L et al. (2018) Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects. Brain Behav Immun 73:34-40
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:
Lindauer, A; Croff, R; Mincks, K et al. (2018) ""It Took the Stress out of Getting Help"": The STAR-C-Telemedicine Mixed Methods Pilot. Care Wkly 2:7-14
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Simon, Matthew J; Wang, Marie X; Murchison, Charles F et al. (2018) Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology. Sci Rep 8:12389
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Croff, Raina L; Witter Iv, Phelps; Walker, Miya L et al. (2018) Things Are Changing so Fast: Integrative Technology for Preserving Cognitive Health and Community History. Gerontologist :
Boespflug, Erin L; Simon, Matthew J; Leonard, Emmalyn et al. (2018) Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease. J Alzheimers Dis 66:1587-1597
Proulx, Jeffrey; Croff, Raina; Oken, Barry et al. (2018) Considerations for Research and Development of Culturally Relevant Mindfulness Interventions in American Minority Communities. Mindfulness (N Y) 9:361-370
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194

Showing the most recent 10 out of 482 publications